Get in touch
555-555-5555
mymail@mailservice.com
Chemicals and Life Sciences
M&A Director
M&A Director
Q1 2021
The newsletter for M&A and corporate development directors
of mid-market chemicals and life sciences businesses
of mid-market chemicals and life sciences businesses
Dear Reader,
I'm delighted to introduce our first newsletter of 2021.
2020 is behind us and, although 2021 is not going to instantly return the world to normal (in fact far from it - see our articles and recommended reading sections below), we are starting to accept at least a tentatively more positive view of the future.
We are all very busy here at CCD Partners working out how all the major changes to the global economy are going to impact our clients and our clients' potential deal partners, and putting in place the work required for our clients to hit the ground running when things start returning to normal.
Once again writing from the home-office, I hope you enjoy our first 2021 newsletter.
Matt Dixon, CCD Partners
Featured Article
2021 - An SME Outlook
Against a backdrop of unprecedented disruption, there are likely to be transformative opportunities for strategically-minded SME chemical and life science business owners.
Deal Summary
Our focus is on the smaller private market deals that tend to be less reported in major publications. We have tracked more than 40 such M&A transaction announcements in the last quarter.
Our top six deals from last quarter are:
| Target | Buyer | Seller | Target Sector | Synopsis / Title |
|---|---|---|---|---|
| Nardev | Barentz | Private | Chemical Distribution and Support Services | Barentz Acquires Personal Care Specialist Nardev, and Strengthens Asia-Pacific Position |
| Porocel Group | Evonik | Private | Specialty Chemicals and Advanced Materials | Evonik successfully completes acquisition of Porocel |
| Pharmaceuticals business | IMCD | Peak International | Chemical Distribution and Support Services | IMCD to acquire the API business of Peak International |
| Fragrances business unit | Symrise | Sensient Technologies Corp | Specialty Chemicals and Advanced Materials | Symrise to expand Scent & Care Activities through Acquisition of Sensient’s Fragrances Business Unit |
| Microbiome Labs | Novozymes | Private | Fine Chemicals and Life Science Contract Services | Novozymes acquires US probiotics producer for $125 million |
| Biologics substance facility | WuXi Biologics | Bayer | Fine Chemicals and Life Science Contract Services | Chinese firm to acquire biologics substance facility in Germany from Bayer |
View full list
Sign up to our weekly trackerKey Appointments
We track the career movement of senior executives instrumental in shaping strategic organisational development through transformative transactions or other means.
Our top six moves from last quarter are:
| Name | From | To | Role |
|---|---|---|---|
| Martin Brudermuller | BASF | Internal appointment | CEO |
| Marc Gilson | Dow Corning | Mitsubishi Chemical | CEO |
| Pierre-Alain Ruffieux | Roche | Lonza | CEO |
| Eduardo Salinas | HCS | Azelis Americas | Managing Director |
| Conrad Keijzer | Imerys | Clariant | CEO & Director |
| Adriano Alfani | Dow | Versalis | CEO |
View full list
Sign up to our weekly trackerPartner Insights
ANDRE SCHOMMER
Head of Strategic Consulting
Covid-19 Pandemic and Post-Merger-Integration – Communication makes the difference
Read full article
What Company and Country leaders can learn from each other.
CCD Partners Update
We are delighted to announce the newest member of the CCD Partners team, Matthew Wise.
Matthew has a first in biological sciences, a master’s in finance, has client-facing experience in Shanghai and data analytical / decision-making experience as an FX trader.
Matthew joins CCD Partners as an analyst supporting our M&A and strategy departments, bringing further depth and breadth to our core transformational advisory team.
Matthew, welcome!
Third Party Recommended Reading
2021 Chemical industry outlook
“To succeed amid ongoing challenges in the chemical industry, companies should implement strategic initiatives in areas such as R&D and technology—including both short- and long-term focused efforts. Explore five trends companies in the chemical goods industry could see emerging as they deal with disruption in 2021.”
The state of the chemical industry—it is getting more complex
“Two years ago, we observed a change in investor sentiment toward the chemical industry and speculated about the potential reasons. Now, we revisit those observations to confirm the underlying assumptions and trends.”
Chemicals industry roundup
“Companies will need to rethink their global integrated supply chains and develop more agile and regional ecosystems.”
US chemical industry to return to growth in 2021
“The chemical industry is already in recovery mode from an unusually deep—but short—recession caused by the COVID-19 pandemic, according to a new analysis by the American Chemistry Council (ACC), the US chemical industry’s main trade association.”
Not Signed Up Yet?
Subscribe to our quarterly newsletter
Please enter your email below to ensure you receive this newsletter on a quarterly basis.
For a more frequent update, our weekly top-five pick of global M&A and senior people moves is also available. To receive our "Chemical Highlights" updates please sign up here.
For more content from expert voices in our corporate development community, as well as our own thoughts and viewpoints, visit our
blog.
Contact Us
CCD Partners
Insight | Network | Execution
We are a network of multi-disciplinary specialists united in the common purpose of identifying and delivering the full potential of innovative and impactful chemicals and life sciences businesses.
Get In Touch
